news
Collaborators have shown that the broad spectrum oral antiviral EIDD-2801…
7 April 2020 | By Hannah Balfour (Drug Target Review)
Collaborators have shown that the broad spectrum oral antiviral EIDD-2801 could be a potential prophylactic or therapeutic for COVID-19 and other coronaviruses.